SEC Form 4 · accession 0000899243-19-004265
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger D Dansey
Officer — See Remarks
Period of report
Feb 15, 2019
Accepted (ET)
Feb 20, 2019 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Feb 15, 2019 | A | 5,768 | $0.00 | A | 83,009 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares represent restricted stock units and will be settled in common stock upon vesting.
- F2Shares shall vest at a rate of 25% on each anniversary of the vesting commencement date of February 1, 2019 until all shares are fully vested four years from the vesting commencement date.
- F3Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 359 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2019.
Remarks
Chief Medical Officer 6150 - Other Research